CN
142-30-3
应用筛选条件
关键词:'142-30-3'
显示 61-90 共 351 条结果 关于 "142-30-3" 范围 技术文档
Product Information Sheet - 1910
higher order chromosome
architecture without enzymatically modifying DNA.
J. Cell. Biochem. 69, 127-142, (1998).
8. Kopel, V., et al., Unwinding of the third strand of a
DNA triple helix, a novel activity
Data Sheet - T9533
G., Proc. Natl. Acad. Sci.
USA, 75, 4001 (1978).
2. Massagne, J., Prog. Med. Virol., 32, 142 (1985).
3. Anzano, M., et al., Cancer Res., 42, 4776 (1982).
4. Anzano, M., et al., Proc. Natl. Acad.
Product Information Sheet - A2647
higher order chromosome
architecture without enzymatically modifying DNA.
J. Cell. Biochem. 69, 127-142, (1998).
8. Kopel, V., et al., Unwinding of the third strand of a
DNA triple helix, a novel activity
RABBIT ANTI-P2Y12 RECEPTOR AFFINITY PURIFIED POLYCLONAL ANTIBODY
.5:1
acrylamide:bisacrysmide) minigel (1.5 mm width) at 30 mA/gel ~1-1.5 hours.
3. Transfer in semi-dry system under standard conditions (3 h 100 mA for two minigel gels)
4. Stain the transferred
Data Sheet - T2824
References
1. Sheehan, K.C., et al., J. Immunol., 142, 3884-3893
(1989).
2. Nedwin, G.E., et al., Nucl. Acid Res., 13, 6361-
6373 (1985).
3. Aggarwal, B.B., et al., J. Biol. Chem., 260,
2345
Data Sheet - T7924
G., Proc. Natl. Acad.
Sci. USA, 75, 4001 (1978).
2. Massagne, J., Prog. Med. Virol., 32, 142 (1985).
3. Anzano, M., et al., Cancer Res., 42, 4776 (19-
82).
4. Anzano, M., et al., Proc. Natl. Acad
Data Sheet - 17231
. S., Van Dipen H. M. J., Vendring C. M. A. and Zoutewelle G., 1956,
J. Appl. Microbiol., 19:142.
3. Mossel R. S., 1959, J. Sci. Food Agric., 19:662.
4. Downes F. P. and Ito K., (Eds.), 2001
Data Sheet - H7412
Yasuda, K., et al., J. Biol. Chem., 270,
29718-29723 (1995).
3. Ishihara, K., et al., Biochem. Biophys. Acta, 1444,
138-142 (1999).
4. Hylander, B.L., et al., Brain Res., 869, 49-55
(2000
Product Information Sheet - I2767
Development, Production, and Safety of
Biosynthetic Human Insulin, Diabetes Care 16
(Suppl 3), 133-142 (1993).
3. Johnson, IS. Authenticity and purity of human
insulin (recombinant DNA). Diabetes Care
Data Sheet - CH0001
17%): B (17%)
A (17%): C (67%): B (17%) A (17%): C (17%): B (67%)
6=119%
3=114%
2=115%
1=100%
A
B C
4=142%
5=119%
10=129%
9=120%8=135%
7=141%
Fig. 5 Criteria =
Product Information Sheet - I0259
Development, Production, and Safety of
Biosynthetic Human Insulin, Diabetes Care 16
(Suppl 3), 133-142 (1993).
3. Johnson, IS. Authenticity and purity of human
insulin (recombinant DNA). Diabetes Care
Monoclonal Anti-BrdU antibody produced in mouse (B8434)
G1282-G1291 (2000).
2. Chen, W. et al., Development, 128, 2385-2396
(2001).
3. Binghua, Z. et al., Endocrinology, 142, 3598-3606
(2001).
4. Britto, J. et al., Nature Neuro., 5, 103-110 (2002).
RABBIT ANTI-p-TYRAMINE
Support: T: 1-800-MILLIPORE (1-800-645-5476) • F: 1-800-437-7502
www.millipore.com
12-30-2005/AB124/CB
3. RAT PERFUSION - Open the animal's thorax and rapidly cannulate the aorta via the left ventricle
Data Sheet 1.46717.0020 / 1.46717.0100
two-dimensional 20-digit serial number, which harbors the following information:
digits 1-3: here code 142 (corresponds to article 146717); digits 4-9: lot number; digits 10-14: batch
specific individual
Product Information Sheet - C6788
157-164 (2002).
7. Hawkes, R. et al., Anal. Biochem., 119(1),
142-147 (1982),
8. Hardie, K.R. et al., J. Med. Microbiol., 39(3),
218-224 (1993).
9. Bakrač, B. et al., J. Biol. Chem., 283(27
Datasheet - F4042
Investigation of Disease Pathogenesis”. Case
Western Reserve University, Ph.D. dissertation,
pp. 139-142 (January 2012).
4. Liburd, Janine Desirée, “Structural Insights into
Dictyostelium discoideum Myosin
JULABO Catalog 2011 en
.. +30 - - - 0.22 0.18 - - -
133
kW V / Hz / A cm kg
1 Pt100 1 Pt100 2 IP31 230/50-60/10 17 x 17 x 16
Data Sheet - C8080 - Lot 045H4844
Immunol., 141, 4388 (1988).
4. Tedder, T., et al., J. Immunol., 142, 2560 (1989).
5. Ledbetter, J., and Clark, E., Human Immunology, 15, 30
(1986).
6. Tedder, T., and Engel, P., Immunology Today, 15
Data Sheet - H107
p-Aminoclonidine HCl (B-002) 0.43 1.4 3.3
(±)-p-Aminoglutethimide (A-122) 0.16 1.2 7.5
R(+)-Atenolol (A-142) 600
S(–)Atenolol (A-143) 600
Butaclamol (D-033, D-034) 0.25 5.4 21
Chloramphenicol
Data Sheet - H7287
Yasuda, K., et al., J. Biol. Chem., 270,
29718-29723 (1995).
3. Ishihara, K., et al., Biochem. Biophys. Acta, 1444,
138-142 (1999).
4. Hylander, B.L., et al., Brain Res., 869, 49-55
(2000
Data Sheet - C8080
.
3. Tedder, T., et al., Proc. Natl. Acad. Sci., USA,
85, 208 (1988).
4. Tedder, T., et al., J. Immunol., 142, 2560
(1989).
5. Ledbetter, J., and Clark, E., Human
Immunology, 15, 30
Data_Sheet-SCC412
Mellon PL. Endocrinology 2001;
142(6):2284-2295.
6. Ruf-Zamojski F et al. Front Endocrinol (Lausanne) 2018; 9:34.
7. Ruf-Zamojski F et al. J Endocr Soc 2019; 3(5):902–920.
Groundwater Sampling Capsules
Division:
Tel. +33 3 88 38 9536
Fax +33 3 88 38 9539
BioPharmaceutical Division:
Tel. +43 1 877-8926
Fax +43 1 877-1654
Laboratory Water Division:
Tel. +33 1 30 12 7000
Fax +33 1 30 12 7180
FINLAND
Data Sheet - P8412
mg 5 mL
P8806 3 mg 7.5 mL
P8787 4 mg 10 mL
P3804** 5 mg 12.5 mL
P6912** 5 mg 12.5 mL
P8287 10 mg 25 mL
Data Sheet - SRP5090
protein tyrosine kinase
inhibits CD25 expression in human T-lymphocytes.
Immunol. Lett., 127, 135-142 (2010).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
TD,MAM 11/11-1
2011
Data Sheet - F3791
, 4388 (1988).
3. Tedder, T., et al., Proc. Natl. Acad. Sci. USA, 85,
4. Tedder, T., et al., J. Immunol., 142, 2560 (1989).
5. Ledbetter, J., and Clark, E., Human Immunology,
15, 30 (1986).
6. Tedder
Data Sheet - P0061
mM
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼142 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 80–108 nmole/min/mg (see Figure
Data Sheet - SRP5320
-2 and protein 4.1 and localizes to the
basolateral membrane of epithelial cells. J. Cell
Biol., 142, 129-138 (1998).
PRECISIO is a registered trademark of Sigma-Aldrich
Co. LLC.
RC,MAM 12/12-1
Product Information Sheet - MAK438
colorectal cancer. Nat.
Cancer, 1(3), 345-358 (2020).
3. Ma, H., et al (2018). Inhibition of SLC1A
5 sensitizes colorectal cancer to
cetuximab. Int. J. Cancer, 142(12),
2578-2588 (2018).
Data Sheet - T0563
G., Proc. Natl. Acad. Sci.
USA, 75, 4001 (1978).
2. Massagne, J., Prog. Med. Virol., 32, 142 (1985).
3. Anzano, M., et al., Cancer Res., 42, 4776 (1982).
4. Anzano, M., et al., Proc. Natl. Acad.
3/12